New product release-Multiplex Respiratory Antigen Rapid Test, IRT9-555

Respiratory diseases pose significant challenges to public health, affecting millions worldwide. Among the most prevalent pathogens are Adenovirus, human Parainfluenza virus (HPIV), and Respiratory Syncytial Virus (RSV), which may?cause severe respiratory infections, especially in vulnerable populations. The emergence of SARS-CoV-2 highlighted the urgent need for effective prevention and treatment strategies. Other notable pathogens?include Mycoplasma pneumoniae (MP), Rhinovirus (RhV), Influenza A and B (Flu A and B) and human metapneumovirus (HMPV). In response to these ongoing health threats, our company is excited to introduce a groundbreaking product?-- new generation respiratory infections test --?aimed at enhancing respiratory health and combating these infectious agents.

What is new?

Upgrading from 5 in 1 to 9 in 1, now detecting 9 analytes in a single kit!

Including Adenovirus, human Parainfluenza virus (HPIV), Respiratory Syncytial Virus (RSV), SARS-CoV-2, M.pneumonide (MP), Rhinovirus (RhV), Influenza A and B (Flu A and B) and human metapneumovirus (HMPV).

?

Why Choose our Product?

Broad Spectrum Detection: The kit covers a wider range of respiratory pathogens, ensuring a more inclusive diagnostic approach that identifies multiple infections simultaneously.

Time-Saving: the 9-in-1 kit offers fast result in just 15 minutes, streamlines the diagnostic process, saving valuable time for both patients and healthcare professionals.

High-Quality Diagnostics: The advanced technology of the 9-in-1 kit ensures precise and dependable results, enabling informed and prompt treatment choices.

Cost-Effective: Reducing the need for multiple tests saves on costs of individual assays, making the 9-in-1 kit a more economical choice for laboratories and healthcare facilities.

?

Where to use?